nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Respiratory failure—Vandetanib—thyroid cancer	0.0416	0.0416	CcSEcCtD
Levorphanol—Lethargy—Vandetanib—thyroid cancer	0.0303	0.0303	CcSEcCtD
Levorphanol—Cardiac arrest—Vandetanib—thyroid cancer	0.0282	0.0282	CcSEcCtD
Levorphanol—Dysuria—Vandetanib—thyroid cancer	0.024	0.024	CcSEcCtD
Levorphanol—Renal failure—Vandetanib—thyroid cancer	0.0225	0.0225	CcSEcCtD
Levorphanol—Bradycardia—Vandetanib—thyroid cancer	0.0209	0.0209	CcSEcCtD
Levorphanol—Visual impairment—Vandetanib—thyroid cancer	0.0198	0.0198	CcSEcCtD
Levorphanol—Mood swings—Sorafenib—thyroid cancer	0.019	0.019	CcSEcCtD
Levorphanol—Arrhythmia—Vandetanib—thyroid cancer	0.0183	0.0183	CcSEcCtD
Levorphanol—Muscle spasms—Vandetanib—thyroid cancer	0.0172	0.0172	CcSEcCtD
Levorphanol—Convulsion—Vandetanib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Levorphanol—Renal failure—Sorafenib—thyroid cancer	0.0152	0.0152	CcSEcCtD
Levorphanol—Hypokinesia—Epirubicin—thyroid cancer	0.0151	0.0151	CcSEcCtD
Levorphanol—Dry mouth—Vandetanib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—thyroid cancer	0.014	0.014	CcSEcCtD
Levorphanol—Insomnia—Vandetanib—thyroid cancer	0.0132	0.0132	CcSEcCtD
Levorphanol—Flushing—Sorafenib—thyroid cancer	0.0128	0.0128	CcSEcCtD
Levorphanol—Dyspepsia—Vandetanib—thyroid cancer	0.0128	0.0128	CcSEcCtD
Levorphanol—Constipation—Vandetanib—thyroid cancer	0.0125	0.0125	CcSEcCtD
Levorphanol—Arrhythmia—Sorafenib—thyroid cancer	0.0124	0.0124	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Levorphanol—Muscle spasms—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Levorphanol—Abdominal pain—Vandetanib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Levorphanol—Thinking abnormal—Epirubicin—thyroid cancer	0.0111	0.0111	CcSEcCtD
Levorphanol—Dyskinesia—Epirubicin—thyroid cancer	0.0108	0.0108	CcSEcCtD
Levorphanol—Pruritus—Vandetanib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—thyroid cancer	0.0103	0.0103	CcSEcCtD
Levorphanol—Injection site reaction—Epirubicin—thyroid cancer	0.0101	0.0101	CcSEcCtD
Levorphanol—Abnormal dreams—Epirubicin—thyroid cancer	0.0101	0.0101	CcSEcCtD
Levorphanol—Dry mouth—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—thyroid cancer	0.01	0.01	CcSEcCtD
Levorphanol—Shock—Sorafenib—thyroid cancer	0.00967	0.00967	CcSEcCtD
Levorphanol—Dizziness—Vandetanib—thyroid cancer	0.00964	0.00964	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—thyroid cancer	0.00937	0.00937	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—thyroid cancer	0.00931	0.00931	CcSEcCtD
Levorphanol—Coma—Epirubicin—thyroid cancer	0.00931	0.00931	CcSEcCtD
Levorphanol—Vomiting—Vandetanib—thyroid cancer	0.00927	0.00927	CcSEcCtD
Levorphanol—Rash—Vandetanib—thyroid cancer	0.00919	0.00919	CcSEcCtD
Levorphanol—Dermatitis—Vandetanib—thyroid cancer	0.00918	0.00918	CcSEcCtD
Levorphanol—Abnormal vision—Epirubicin—thyroid cancer	0.00888	0.00888	CcSEcCtD
Levorphanol—Mental disability—Epirubicin—thyroid cancer	0.00884	0.00884	CcSEcCtD
Levorphanol—Nausea—Vandetanib—thyroid cancer	0.00866	0.00866	CcSEcCtD
Levorphanol—Dyspepsia—Sorafenib—thyroid cancer	0.00866	0.00866	CcSEcCtD
Levorphanol—Coma—Doxorubicin—thyroid cancer	0.00861	0.00861	CcSEcCtD
Levorphanol—Constipation—Sorafenib—thyroid cancer	0.00841	0.00841	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—thyroid cancer	0.00822	0.00822	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—thyroid cancer	0.00818	0.00818	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00804	0.00804	CcSEcCtD
Levorphanol—Urticaria—Sorafenib—thyroid cancer	0.00781	0.00781	CcSEcCtD
Levorphanol—Abdominal pain—Sorafenib—thyroid cancer	0.00777	0.00777	CcSEcCtD
Levorphanol—Lethargy—Epirubicin—thyroid cancer	0.00755	0.00755	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—thyroid cancer	0.00739	0.00739	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—thyroid cancer	0.00728	0.00728	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—thyroid cancer	0.00703	0.00703	CcSEcCtD
Levorphanol—Mood swings—Epirubicin—thyroid cancer	0.007	0.007	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—thyroid cancer	0.00698	0.00698	CcSEcCtD
Levorphanol—Pruritus—Sorafenib—thyroid cancer	0.00696	0.00696	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—thyroid cancer	0.00684	0.00684	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—thyroid cancer	0.00673	0.00673	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—thyroid cancer	0.00651	0.00651	CcSEcCtD
Levorphanol—Dizziness—Sorafenib—thyroid cancer	0.0065	0.0065	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—thyroid cancer	0.00648	0.00648	CcSEcCtD
Levorphanol—Vomiting—Sorafenib—thyroid cancer	0.00625	0.00625	CcSEcCtD
Levorphanol—Rash—Sorafenib—thyroid cancer	0.0062	0.0062	CcSEcCtD
Levorphanol—Dermatitis—Sorafenib—thyroid cancer	0.00619	0.00619	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—thyroid cancer	0.00598	0.00598	CcSEcCtD
Levorphanol—Nausea—Sorafenib—thyroid cancer	0.00584	0.00584	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—thyroid cancer	0.0056	0.0056	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—thyroid cancer	0.00553	0.00553	CcSEcCtD
Levorphanol—Sweating—Epirubicin—thyroid cancer	0.00546	0.00546	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—thyroid cancer	0.00521	0.00521	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—thyroid cancer	0.00505	0.00505	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—thyroid cancer	0.00493	0.00493	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—thyroid cancer	0.00482	0.00482	CcSEcCtD
Levorphanol—Flushing—Epirubicin—thyroid cancer	0.00475	0.00475	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—thyroid cancer	0.00457	0.00457	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—thyroid cancer	0.00456	0.00456	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Levorphanol—Tension—Epirubicin—thyroid cancer	0.00437	0.00437	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—thyroid cancer	0.00433	0.00433	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—thyroid cancer	0.00428	0.00428	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—thyroid cancer	0.00423	0.00423	CcSEcCtD
Levorphanol—Agitation—Epirubicin—thyroid cancer	0.00409	0.00409	CcSEcCtD
Levorphanol—Tension—Doxorubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—thyroid cancer	0.004	0.004	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—thyroid cancer	0.00379	0.00379	CcSEcCtD
Levorphanol—Dry mouth—Epirubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—thyroid cancer	0.00366	0.00366	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—thyroid cancer	0.00364	0.00364	CcSEcCtD
Levorphanol—Shock—Epirubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—thyroid cancer	0.00351	0.00351	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—thyroid cancer	0.0034	0.0034	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Levorphanol—Shock—Doxorubicin—thyroid cancer	0.00331	0.00331	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Levorphanol—Constipation—Epirubicin—thyroid cancer	0.00311	0.00311	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—thyroid cancer	0.00304	0.00304	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Levorphanol—Pruritus—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Levorphanol—Vomiting—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Levorphanol—Rash—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Levorphanol—Nausea—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Levorphanol—Rash—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
